Drugs@FDA document

CELEXA Letter · NDA 020822 SUPPL-34

Drugs@FDA document · ABBVIE · Aug 7, 2007

Key facts

Drug name CELEXA
Document type Letter
Application NDA020822
Submission SUPPL-34
Company ABBVIE
Document date Aug 7, 2007

At a glance

  • Labeling Document categories
  • 10–99 Documents for this application
  • None USP chapters cited in this application's documents

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Drugs@FDA documents

Drugs@FDA posts the letters, labels, reviews and other documents behind each drug application and supplement. Orca1 indexes every document's full text and flags complete response letters.

Source: U.S. Food and Drug Administration (FDA), Drugs@FDA application documents · Source date:

Browse all Drugs@FDA documents